The Antares Pharma Portfolio

With four products approved by the FDA in less than 5 years, Antares Pharma continues to build its commercial portfolio with innovative, patient-focused therapeutic options including Otrexup®, Sumatriptan autoinjector, Zoma-Jet® and Gelnique. Our internal development team specializes in creating custom designed devices that fit the device to the patient and therapeutic need.